The FDA's Real-Time Oncology Review program may be showing the way to fast approvals under the Commissioner's National Priority Voucher. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
